Blood Tests That Personalize Antidepressants Show Age, BMI, and Kidneys Drive Dosing
A validated UPLC-MS/MS method analyzing 566 plasma samples reveals key patient factors that explain why standard antidepressant doses fail many people.
975 articles in this topic
A validated UPLC-MS/MS method analyzing 566 plasma samples reveals key patient factors that explain why standard antidepressant doses fail many people.
OSK gene therapy targeting engram neurons restored memory to youthful levels in aged mice and Alzheimer's models, reversing senescence hallmarks.
A completed pilot trial tests adapted Dialectical Behavior Therapy to reduce suicidality in aging family caregivers of AD/ADRD patients.
A 35-year-old woman experienced reproducible dystonic episodes triggered solely by pressure on her right upper limb — a rare neurological phenomenon.
A UCLA neurologist proposes a unified terminology system for ischemic core size in acute stroke, potentially improving clinical communication and trial design.
A naturally occurring fatty acid amide activates immune cells in the retina, protecting neurons and blood vessels from degenerative damage.
New imaging reveals how electrical signals travel through cortical dendrites in living mice, reshaping models of memory and plasticity.
A molecule called OLE restores microglia's protective function, reducing amyloid plaques and improving memory in animal models.
UC Riverside researchers show amyloid beta may displace tau from neurons, triggering brain cell breakdown before plaques even form.
Long-term intensive training reshapes hemispheric brain organization in elite athletes, and these changes prove resilient to sport-related concussions.
The SenNet atlas reveals where aging cells accumulate in human tissues, opening new doors for senolytic therapies and healthspan extension.
Early-life exposure to DEHP, a plasticizer in everyday products, caused lasting anxiety in male rats — and GABA or testosterone reversed it.